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Summary. Background: Factors contributing to the generation
of soluble P- and E-selectins remain unclear. Results: This
work demonstrates that mice lacking P-selectin glycoprotein
ligand-1 (Psgl-1)/)) are deficient in soluble P-selectin (sP-sel),
which is due to a defective binding interaction between PSGL-1
and P-sel, because mice lacking a(1,3)-fucosyltransferase-VII
are also deficient in sP-sel. Psgl-1)/) mice are also deficient in
soluble E-selectin (sE-sel) indicating that leukocyte interactions
with endothelial cells lead to the generation of sE-sel. The
generation of sE-sel requires an interaction between PSGL-1
and P-sel, as deficiency of sE-sel is observed in both Psgl-1)/)
andP-sel)/)mice. Bonemarrow transplantation fromPsgl-1)/)
to Psgl-1+/+ mice leads to deficiency of sP-sel and sE-sel in
recipient mice, establishing the importance of bone marrow-
derived PSGL-1 toward the generation of sP-sel and sE-sel.
Bone marrow transplantation from P-sel)/) to P-sel1+/+ mice
does not lead to a significant reduction in sP-sel, confirming the
importance of the endothelium toward the liberation of
sP-sel. Conclusion: sP-sel and sE-sel reflect an interaction
between leukocyte PSGL-1 and endothelial P-sel.
Keywords: adhesion, endothelium, leukocyte, platelets, throm-
bosis.
Introduction
The selectins (P, E, and L) are a class of adhesion molecules
that play important roles in many physiologic processes,
including leukocyte rolling and adhesion on endothelial cells
[1]. P-selectin (P-sel) is present in platelet a-granules and
endothelial cell Weibel–Palade bodies and is rapidly expressed
on the cell surface following stimulation [2,3]. E-selectin (E-sel)
is expressed on endothelial cells following cytokine stimulation
[4] and L-selectin (L-sel) is expressed on leukocytes [5].
Deficiency of one or more of these selectins has been shown
to alter vascular disease processes in several preclinical models
[6]. Although the membrane-bound selectins mediate cell–cell
interactions in the vasculature, each selectin also has a soluble
form (sE-sel, sP-sel, and sL-sel) that can be measured in the
plasma [5,7,8]. The soluble selectins have been used as markers
of vascular disease processes [9] and may play direct roles in
inflammatory disease processes [5,7,8].
A physiologically important endogenous ligand for the
selectins is P-sel glycoprotein ligand-1 (PSGL-1), which is
expressed primarily on leukocytes [10] and requires a(1,3)-
fucosylation for binding activity [11,12]. Several studies have
demonstrated that adhesive interactions between selectins and
PSGL-1 facilitate leukocyte rolling on endothelial cells [13,14]
and mediate the formation of platelet–leukocyte aggregates
[15]. Deficiency of PSGL-1 in mice is associated with impaired
leukocyte rolling and reduced generation of procoagulant
microparticles [16,17]. Because elevated levels of soluble
selectins are associated with disease processes that require
selectin/selectin-ligand interactions, we tested the hypothesis
that generation of soluble selectins is regulated by interaction
with a physiologic ligand.
Methods
Mice
Psgl-1)/) and P-sel)/) mice were purchased from Jackson
Laboratory, Bar Harbor, ME, USA. a(1,3)-Fucosyltransf-
erase-VII-deficient mice (FucT-VII)/)) were previously gener-
ated [11] and compared with wild-type mice from the same
colony. All mice had previously been backcrossed several
generations to the C57BL6/J background strain (P-sel)/) mice
>10 generations; Psgl-1)/) mice ¼ 6 generations; FucT-VII)/)
mice ¼ 10 generations).
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Measurement of circulating selectins (P, E, and L) and vascular
cell adhesion molecule-1
Enzyme-linked immunosorbent assays (R&D Systems, Inc.,
Minneapolis, MN, USA) were used to determine the
concentrations of soluble murine P-, E-, and L-selectin,
and vascular cell adhesion molecule-1 (VCAM-1) in mouse
serum. Measurement of platelet P-sel was performed as
previously described [18] using Triton X-100 on washed
platelets followed by measurement of P-sel in the platelet
supernatant.
Bone marrow transplantation
Bone marrow transplantation experiments from P-sel)/), Psgl-
1)/) and wild-type donors to irradiated wild-type recipients
were performed as previously described [19].
Results
Effect of PSGL-1 expression and binding capacity on
generation of soluble selectins
To determine if selectin interactions with their ligands affects
the generation of soluble selectins, sP-sel from mice deficient in
the corresponding ligand, PSGL-1, was measured. Serum
samples from Psgl-1+/+ mice contained 4.6-fold greater sP-sel
than serum from Psgl-1)/) mice (Fig. 1A). In contrast, total
platelet P-sel levels were not reduced in Psgl-1)/) mice
compared with wild-type mice (1.97 ± 0.06 vs.
1.56 ± 0.09 ng mL)1). Concentrations of sP-sel were not
different between PSGL-1 heterozygotes (Psgl-1+/)) and
Psgl-1+/+ mice (123 ± 3.3 vs. 116 ± 2.3 ng mL)1; n ¼ 6
per genotype; P ¼ ns).
Because a(1,3)-fucosylation of PSGL-1 by the myeloid
a(1,3)-fucosyltransferase-VII directs expression of the PSGL-1
binding glycoform toward P-sel [11,20], sP-sel was also
measured in FucT-VII)/) mice. Consistent with a role for
ligand binding to P-sel in the generation of sP-sel, FucT-VII)/)
mice were also deficient in sP-sel (Fig. 1B).
Concentrations of the circulating endothelial-specific selec-
tin, sE-sel, were also measured in Psgl-1+/+ and Psgl-1)/)
mice. Serum from Psgl-1+/+ mice contained 3.2-fold greater
sE-sel than serum from Psgl-1)/) mice (Fig. 2A). Similarly,
FucT-VII)/) mice showed reduced sE-sel (Fig. 2B). Circulating
levels of VCAM-1, an endothelial adhesion molecule with
expression that is under regulatory influences similar to those of
E-sel [21], were not different between Psgl-1)/) and Psgl-1+/+
mice (947 ± 49 vs. 913 ± 49 ng mL)1; n ¼ 5 per group;
P ¼ ns). sE-sel levels in P-sel )/) mice were reduced to levels
similar to those observed in Psgl-1)/) mice (Fig. 2C).
To determine if PSGL-1 affected generation of sL-sel, we
measured sL-sel in Psgl-1+/+ and Psgl-1)/) mice. sL-sel was
actually increased in Psgl-1)/) mice compared with Psgl-1+/+
mice (1.85 ± 0.068 vs. 1.63 ± 0.030 lg mL)1; n ¼ 6 per
group; P ¼ 0.01).
Effect of PSGL-1- and P-sel-deficient bone marrow
transplantation on levels of soluble selectins
To determine the relevant PSGL-1 tissue compartment for
generation of sP-sel, we performed bone marrow transplanta-
tion from Psgl-1)/) into Psgl-1+/+mice. sP-sel and sE-sel were
markedly reduced compared with transplanted wild-type
controls (Fig. 3A,B). In contrast, P-sel)/) bone marrow did
not significantly affect sP-sel levels in P-sel+/+ recipients (n ¼
4; sP-sel ¼ 157 ± 15 ng mL)1).
Discussion
Selectins have previously been shown to play important roles
in the development of atherosclerosis and thrombosis [22–24].
Circulating soluble forms of selectins have direct effects on
vascular events such as thrombosis [7] and have been used as
markers of disease processes [9], although the factors
involved in the generation of sP-sel and sE-sel are not well-
characterized.
The primary ligand for P-sel, PSGL-1, is expressed predom-
inantly on leukocytes. To test the physiologic role of PSGL-1 in
regulating sP-sel concentrations in vivo, we measured sP-sel in

















































Fig. 1. Effect of P-selectin glycoprotein ligand-1 (PSGL-1) or a(1,3)-fuc-
osyltransferase-VII (FucT-VII) deficiency on soluble P-selectin (sP-sel)
levels. (A) sP-sel levels in Psgl-1+/+mice (n ¼ 6) compared with Psgl-1)/)
mice (n ¼ 6); *P < 0.00001. (B) sP-sel levels in FucT-VII+/+ mice
(n ¼ 6) compared with FucT-VII)/) mice (n ¼ 6); *P < 0.00001.
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reduced levels of sP-sel, but slightly increased total platelet P-sel
levels, indicating that the ligand is playing a role in the
generation of sP-sel. The selectin-binding glycoform of PSGL-1
is regulated by a(1,3)-fucosylation, and leukocytes from mice
deficient in FucT-VII have been shown to lack the capacity to
bind P-sel [11]. Our finding that FucT-VII)/) mice are deficient
in sP-sel demonstrates that a functional binding interaction
between PSGL-1 and P-sel is required for the generation of sP-
sel in vivo. The modest differences between baseline levels of sP-
sel in the wild-type controls of the Psgl-1)/) and FucT-VII)/)
mice may reflect minor differences in serum collection
techniques.
It has been previously demonstrated, using bone marrow
transplantation techniques, that the predominant source of sP-
sel in atherosclerotic-pronemice is the endothelium, with only a
minor contribution fromplatelets [25].We have now confirmed
in non-atherosclerotic mice, using bone marrow transplanta-
tion, that the vast majority of sP-sel in mice is derived from a
non-bone marrow source (i.e. endothelium) as no significant
effect was observed when P-sel)/) bone marrow was trans-
planted into P-sel+/+ mice.
To further explore potentially relevant tissue sources of
circulating selectins specifically regulated by PSGL-1, concen-
trations of the circulating endothelial-specific selectin, sE-sel,
were also measured inPsgl-1+/+ andPsgl-1)/) mice. Although
PSGL-1may be a relativelyminor E-sel ligand [26], serum from
Psgl-1)/) mice was deficient in sE-sel. Similarly, serum from
FucT-VII)/) mice was also deficient in sE-sel compared with
FucT-VII+/+ mice. Thus, sE-sel levels are dependent on
PSGL-1 expression and a(1,3)-fucosylation, again indicating
an important role for binding interactions between PSGL-1
and an endothelial selectin. In contrast, circulating levels of
VCAM-1 were not different between Psgl-1)/) and Psgl-1+/+









































































Fig. 2. Effect of P-selectin glycoprotein ligand-1 (PSGL-1) or a(1,3)-fuc-
osyltransferase-VII (FucT-VII) deficiency on soluble E-selectin (sE-sel)
levels. (A) sE-sel levels in Psgl-1+/+mice (n ¼ 4) compared with Psgl-1)/)
mice (n ¼ 4); *P < 0.00001. (B) sE-sel levels in FucT-VII+/+ mice
(n ¼ 4) comparedwithFucT-VII)/)mice (n ¼ 4);P < 0.00001. (C) sE-sel
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Fig. 3. Effect of bone marrow transplantation on soluble P-selectin
(sP-sel) and soluble E-selectin (sE-sel) levels. (A) sP-sel levels in P-selectin
glycoprotein ligand-1 (Psgl-1+/+) mice transplanted with Psgl-1+/+ or
Psgl-1)/) bone marrow (n ¼ 5 per genotype); *P < 0.00001. (B) sE-sel
levels in Psgl-1+/+ mice transplanted with Psgl-1+/+ or Psgl-1)/) bone
marrow (n ¼ 10); *P < 0.001.
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The endothelial-specific expression of E-sel indicates that the
endothelial cell is the source of PSGL-1-dependent sE-sel
generation. To determine whether generation of sE-sel is due to
a direct interaction of PSGL-1 with E-sel or secondary to a
facilitative role of PSGL-1 with P-sel, sE-sel levels were
measured in P-sel)/) mice. sE-sel levels in P-sel)/) mice were
reduced to levels similar to those observed in Psgl-1)/) mice,
indicating that generation of sE-sel is due to ligands other than
PSGL-1 and that interaction of these other ligands with E-sel
may require initial interactions between PSGL-1 and P-sel. For
example, a previous study demonstrated reduced leukocyte
rolling on E-sel following treatment with an antibody to block
P-sel [27]. Alternatively, based on the present work, we cannot
rule out that an interaction between PSGL-1 and P-sel could
lead to endothelial secretion of sE-sel. sP-sel and sE-sel may
therefore be generated during leukocyte interactions, such as
rolling, with the endothelium, and selectin shedding may
actually be required for efficient rolling. L-sel shedding has
been previously shown to occur rapidly during the process of
leukocyte rolling in an in vitro hydrodynamic flow model, and
inhibition of the shedding process with a metalloprotease
inhibitor reduced neutrophil rolling, leading to increased
neutrophil accumulation [28]. However, it is not clear from
our data at which stage of leukocyte interaction with endot-
helial cells soluble selectin shedding occurs. For example, P-sel
may be cleaved after leukocyte arrest or during transmigration.
In addition to leukocytes, PSGL-1 has also been shown to be
present on endothelial cells and to bind P-sel [29]. To test the
role of bone marrow-derived PSGL-1 on the generation of sP-
sel and sE-sel, we performed bone marrow transplantation
from Psgl-1)/) to Psgl-1+/+ mice. This transplant produced
the deficiency state of sP-sel and sE-sel, supporting the role of
leukocyte PSGL-1 in the generation of soluble selectins.
Although we have shown the importance of a(1,3)-fucosyl-
ated PSGL-1 in the generation of sP-sel and sE-sel in vivo,
Psgl1)/) mice are not completely deficient in these circulating
selectins. This suggests either that there is ligand-independent
shedding or that ligands other than PSGL-1 also contribute to
sP-sel and sE-sel generation. It is also possible that during
inflammatory states in which soluble selectins are elevated, the
mechanisms responsible for their generation are different from
themechanisms responsible for the generation of basal levels of
circulating selectins. These important issues will need to be
addressed in various models of inflammatory diseases.
In conclusion, this study demonstrates a requirement for
bone marrow-derived PSGL-1 and a(1,3)-fucosyltransferase
activity in the generation of sP-sel and sE-sel levels in vivo.
These findings indicate that circulating selectins are specific
markers of leukocyte interactions with endothelial cells, and
will serve as an extremely valuable tool in tracking ligand–
selectin interactions in vivo. The presence of persistent circu-
lating adhesion molecules in the circulation indicates that
generation of circulating selectins is part of an ongoing
physiologic process reflecting cell–cell interactions, and that
selectin shedding may play an important regulatory role in
leukocyte adhesive interactions with endothelial cells.
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